Find care

Are Psychedelics Legal? U.S. Treatment Access Explained

Are psychedelics legal? There is no single U.S. answer: the substance, activity and jurisdiction matter. Psilocybin and MDMA remain federally controlled Schedule I substances; Oregon and Colorado have separate state-regulated psilocybin access systems. Ketamine prescribing and FDA-approved Spravato follow a different medical and controlled-substance framework.

A state service license, reduced local enforcement, a research designation and FDA approval are different things. Before booking, verify the exact service and location rather than accepting a broad “legal psychedelic therapy” claim.

The main access routes are different

RouteWhat it does establishWhat it does not establish
Spravato treatmentAn approved esketamine product used within its labeled indications and required settingThat all ketamine products have the same approval
Prescribed ketamineA separate medical and controlled-substance prescribing frameworkFDA approval of psychiatric ketamine use or any compounded ketamine product
Oregon or Colorado regulated servicesA state access framework with rules and licensesA change to federal drug law or FDA approval
Authorized clinical researchA study may investigate an unapproved treatment with regulatory oversightGeneral commercial approval or guaranteed enrollment
Local decriminalizationA particular jurisdiction may reduce penalties or enforcement prioritiesFDA approval or permission to run a commercial treatment service

Sources: DEA controlled-substance list, dated November 12, 2026, FDA Spravato guide, Oregon access guidance and Denver government guidance.

Federal status and state access can coexist

The DEA's current list identifies psilocybin and MDMA as Schedule I. Oregon's own informed-consent materials explain that its state program does not change federal law. This distinction should remain clear when someone advertises a retreat or treatment as “legal.”

A state license is not an FDA drug approval. A breakthrough therapy designation, clinical trial, priority review or submitted application is not approval either. The FDA's psychedelic-drug development page describes ongoing research and regulatory work. Do not interpret a pipeline headline as a treatment you can purchase through an ordinary prescription.

The VA's patient information on MDMA explains that MDMA is not FDA-approved for clinical use and remains a research treatment. We do not list a commercial MDMA provider as an ordinary approved treatment route.

What Oregon permits through its licensed program

Oregon's program serves adults 21 and older. A prescription, medical referral and Oregon residency are not required. Access involves preparation and an administration session with a licensed facilitator at a licensed service center. Products cannot be purchased there to take home.

Oregon describes these as psilocybin services, rather than a medical or clinical treatment. A facilitator license is not automatically a healthcare license. If a provider also offers psychotherapy or medical care, verify the separate credentials and what is included. Sources: OHA access guidance and OHA informed consent.

To find services, use the Oregon Psilocybin Services licensee directory. The directory is optional for licensees and is not the license-verification tool. Follow OHA's separate license-status link to check the license number and type. A directory listing is not an endorsement or proof that a service is right for you.

What to verify in Colorado

Colorado has a state-regulated natural-medicine system. Use the Natural Medicine Division for regulated-business information and DORA's Natural Medicine program for facilitator credentials. Ask which license covers the activity and whether the proposed location is permitted.

Do not assume every regulated session must occur at a healing center. Denver's government guidance also describes administration with a licensed facilitator at a home or healthcare facility. That is not blanket permission for any home retreat or unlicensed guide.

Personal-use provisions are separate from commercial licensing. Local requirements can also apply. A provider should identify the exact authority for the service it sells rather than relying on a broad claim that mushrooms are decriminalized.

Ketamine is Schedule III rather than Schedule I. Its psychiatric use is off-label, while Spravato is a distinct approved esketamine product. Compounded ketamine is not FDA-approved. See Spravato vs ketamine for the product differences.

As checked November 17, 2026, HHS says temporary federal telemedicine flexibilities extend through December 31, 2026. Required conditions, clinician authority and state rules still apply. Do not read that deadline as a permanent rule or a guarantee of access from any state.

Confirm the provider can serve the place where you will receive treatment. A working checkout page or a national advertisement is not evidence of prescribing authority.

A verification checklist before you pay

  1. Identify the exact substance, product, activity and location.
  2. Check the relevant business and professional license with the regulator.
  3. Ask what screening and preparation are required and who can decline services.
  4. Confirm what the price includes and what happens if screening excludes you.
  5. Ask about monitoring, transport, aftercare and emergency procedures.
  6. Verify any claim that a product is FDA-approved or a service is legally authorized.

If you cannot establish the legal basis for a service, seek guidance from the regulator or a qualified lawyer before committing. A provider's claim of a religious, ceremonial or other exception should not be treated as automatic authorization for every substance, person or commercial activity.

How to check a research opportunity

Use ClinicalTrials.gov to identify a study, then confirm its recruiting status, sponsor, site and eligibility with the listed research team. A registry listing does not mean the treatment is approved, that the study is recruiting locally, or that you qualify. Do not stop existing care or travel on the assumption that you will be enrolled.

Scope and check date

Checked November 17, 2026 against the primary sources linked above. This page explains major U.S. access distinctions, not every municipal ordinance or an individual legal opinion. Rules, licensing and federal approvals can change; verify the actual service before booking. Legality also does not establish medical suitability or safety.